Ben Lamm

Co-founder & CEO, Colossal Biosciences

Search every verified Ben Lamm interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Ben Lamm, co-founder and CEO of Colossal Biosciences, discussed the company's work in de-extinction and its AI biology spinout, Astromech, in a recent interview. He stated that Colossal has raised $635 million in total funding and described the development of genetically engineered "woolly mice" as part of research toward reviving the woolly mammoth. Lamm also mentioned that Astromech is valued at $3.8 billion and focuses on using AI for biology applications. In the interview, Lamm addressed criticism from the conservation community, saying that Colossal does not view de-extinction as a replacement for modern conservation efforts but rather as a complement. He cited projections of losing up to 50% of biodiversity in the next 25 years and discussed potential applications of genetic technologies, such as gene drives to address invasive species, which he described as a significant global problem. He also noted that the company receives requests to work on species like the Megalodon but is not pursuing that project.